This chapter presents an overview of disease burden research in China. The presentation in this chapter shows China’s early involvement in the GBD study. Vital statistics, population census, disease surveillance point system, mandatory infectious disease reporting system, national annual reports on maternal and child health, cancer registries, the Sino-MONICA project，and multiple specialized epidemiological surveys in China have provided extensive data support for estimating changes in disease patterns in the Chinese population. The GBD China study shows that the Chinese population is undergoing a rapid transformation in health patterns, life expectancy is increasing rapidly, and mortality and morbidity of communicable diseases, maternal and infant diseases, acute rheumatic fever and rheumatic heart disease are decreasing; chronic non- communicable diseases such as ischemic heart disease, stroke, diabetes, and cancer are increasing significantly. Compared with the populations of G20 countries, the specific causes mortality, and years of life lost (YLL) of stroke, lung cancer and several digestive cancers in Chinese are higher than those of other G20 countries. The differences in the distribution of mortality and morbidity of non-communicable diseases such as maternal and child diseases, cardiovascular and cerebrovascular diseases among provinces or counties in China shown in this chapter suggest the imbalance in the imbalance of socio-economic development in China. The GBD China study has the following advantages over the local study: (1) the comprehensive analysis of data from different sources is completed; (2) the health status of the Chinese population is evaluated from a global perspective; and (3) the health status of the population is analyzed at the provincial, or even county, level, which is conducive to the promotion of health equity. This is a deficiency of local studies in China. These studies will promote the development of descriptive epidemiology in China. As a result of the more intensive involvement of Chinese experts in the GBD study, it was discovered that GBD 2013 had mis-estimated the mortality trend of coronary heart disease in the Chinese population. The process of identifying problems and making improvements highlights the role of local experts in the GBD study. Local experts are needed not only to provide data, but also to understand the key analytical processes and to judge whether the estimates are correct. Local experts not only serve as a bridge to facilitate policy translation in their own countries, but also contribute to the further refinement of the methodology of the GBD study.

The GBD Study in China

章节
发表日期：

2025年

查看全文

Gonghuan Yang

摘要

This chapter presents an overview of disease burden research in China. The presentation in this chapter shows China’s early involvement in the GBD study. Vital statistics, population census, disease surveillance point system, mandatory infectious disease reporting system, national annual reports on maternal and child health, cancer registries, the Sino-MONICA project，and multiple specialized epidemiological surveys in China have provided extensive data support for estimating changes in disease patterns in the Chinese population. The GBD China study shows that the Chinese population is undergoing a rapid transformation in health patterns, life expectancy is increasing rapidly, and mortality and morbidity of communicable diseases, maternal and infant diseases, acute rheumatic fever and rheumatic heart disease are decreasing; chronic non- communicable diseases such as ischemic heart disease, stroke, diabetes, and cancer are increasing significantly. Compared with the populations of G20 countries, the specific causes mortality, and years of life lost (YLL) of stroke, lung cancer and several digestive cancers in Chinese are higher than those of other G20 countries. The differences in the distribution of mortality and morbidity of non-communicable diseases such as maternal and child diseases, cardiovascular and cerebrovascular diseases among provinces or counties in China shown in this chapter suggest the imbalance in the imbalance of socio-economic development in China. The GBD China study has the following advantages over the local study: (1) the comprehensive analysis of data from different sources is completed; (2) the health status of the Chinese population is evaluated from a global perspective; and (3) the health status of the population is analyzed at the provincial, or even county, level, which is conducive to the promotion of health equity. This is a deficiency of local studies in China. These studies will promote the development of descriptive epidemiology in China. As a result of the more intensive involvement of Chinese experts in the GBD study, it was discovered that GBD 2013 had mis-estimated the mortality trend of coronary heart disease in the Chinese population. The process of identifying problems and making improvements highlights the role of local experts in the GBD study. Local experts are needed not only to provide data, but also to understand the key analytical processes and to judge whether the estimates are correct. Local experts not only serve as a bridge to facilitate policy translation in their own countries, but also contribute to the further refinement of the methodology of the GBD study.